Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Preventing HIV infection without targeting the virus: how reducing HIV target cells at the genital tract is a new approach to HIV prevention.

Lajoie J, Mwangi L, Fowke KR.

AIDS Res Ther. 2017 Sep 12;14(1):46. doi: 10.1186/s12981-017-0166-7. Review.

2.

Efficacy of HIV antiviral polyanionic carbosilane dendrimer G2-S16 in the presence of semen.

Ceña-Diez R, García-Broncano P, de la Mata FJ, Gómez R, Muñoz-Fernández MÁ.

Int J Nanomedicine. 2016 May 30;11:2443-50. doi: 10.2147/IJN.S104292. eCollection 2016.

3.

Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection.

LoRicco JG, Xu CS, Neidleman J, Bergkvist M, Greene WC, Roan NR, Makhatadze GI.

J Biol Chem. 2016 Jul 1;291(27):14045-55. doi: 10.1074/jbc.M116.718684. Epub 2016 May 11.

4.

Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome.

Verstraelen H, Vervaet C, Remon JP.

PLoS One. 2016 Apr 19;11(4):e0153441. doi: 10.1371/journal.pone.0153441. eCollection 2016.

5.

Potential Use of Antimicrobial Peptides as Vaginal Spermicides/Microbicides.

Tanphaichitr N, Srakaew N, Alonzi R, Kiattiburut W, Kongmanas K, Zhi R, Li W, Baker M, Wang G, Hickling D.

Pharmaceuticals (Basel). 2016 Mar 11;9(1). pii: E13. doi: 10.3390/ph9010013. Review.

6.

Immune Activation in the Female Genital Tract: Expression Profiles of Soluble Proteins in Women at High Risk for HIV Infection.

Francis SC, Hou Y, Baisley K, van de Wijgert J, Watson-Jones D, Ao TT, Herrera C, Maganja K, Andreasen A, Kapiga S, Coulton GR, Hayes RJ, Shattock RJ.

PLoS One. 2016 Jan 27;11(1):e0143109. doi: 10.1371/journal.pone.0143109. eCollection 2016.

7.

Biomarkers of Cervical Inflammation and Immunity Associated with Cervical Shedding of HIV-1.

Mauck C, Chen PL, Morrison CS, Fichorova RN, Kwok C, Chipato T, Salata RA, Doncel GF.

AIDS Res Hum Retroviruses. 2016 May;32(5):443-51. doi: 10.1089/AID.2015.0088. Epub 2016 Jan 26.

8.

Microbicides for the Treatment of Sexually Transmitted HIV Infections.

Singh O, Garg T, Rath G, Goyal AK.

J Pharm (Cairo). 2014;2014:352425. doi: 10.1155/2014/352425. Epub 2014 Feb 12. Review.

9.

The Contribution of Cervicovaginal Infections to the Immunomodulatory Effects of Hormonal Contraception.

Fichorova RN, Chen PL, Morrison CS, Doncel GF, Mendonca K, Kwok C, Chipato T, Salata R, Mauck C.

MBio. 2015 Sep 1;6(5):e00221-15. doi: 10.1128/mBio.00221-15.

10.

Unexpected Inflammatory Effects of Intravaginal Gels (Universal Placebo Gel and Nonoxynol-9) on the Upper Female Reproductive Tract: A Randomized Crossover Study.

Smith-McCune K, Chen JC, Greenblatt RM, Shanmugasundaram U, Shacklett BL, Hilton JF, Johnson B, Irwin JC, Giudice LC.

PLoS One. 2015 Jul 15;10(7):e0129769. doi: 10.1371/journal.pone.0129769. eCollection 2015.

11.

Gene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.

Zalenskaya IA, Joseph T, Bavarva J, Yousefieh N, Jackson SS, Fashemi T, Yamamoto HS, Settlage R, Fichorova RN, Doncel GF.

PLoS One. 2015 Jun 8;10(6):e0128557. doi: 10.1371/journal.pone.0128557. eCollection 2015.

12.

HbAHP-25, an In-Silico Designed Peptide, Inhibits HIV-1 Entry by Blocking gp120 Binding to CD4 Receptor.

Bashir T, Patgaonkar M, Kumar SC, Pasi A, Reddy KV.

PLoS One. 2015 Apr 27;10(4):e0124839. doi: 10.1371/journal.pone.0124839. eCollection 2015.

13.

Genital inflammation and the risk of HIV acquisition in women.

Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS.

Clin Infect Dis. 2015 Jul 15;61(2):260-9. doi: 10.1093/cid/civ298. Epub 2015 Apr 21.

14.

Correlates of the molecular vaginal microbiota composition of African women.

Gautam R, Borgdorff H, Jespers V, Francis SC, Verhelst R, Mwaura M, Delany-Moretlwe S, Ndayisaba G, Kyongo JK, Hardy L, Menten J, Crucitti T, Tsivtsivadze E, Schuren F, van de Wijgert JH; Vaginal Biomarkers Study Group.

BMC Infect Dis. 2015 Feb 21;15:86. doi: 10.1186/s12879-015-0831-1.

15.

Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.

Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V.

Clin Vaccine Immunol. 2015 May;22(5):526-38. doi: 10.1128/CVI.00762-14. Epub 2015 Mar 11.

16.

Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.

Cone RA.

J Infect Dis. 2014 Dec 15;210 Suppl 3:S616-21. doi: 10.1093/infdis/jiu459. Review.

17.

Semen enhances HIV infectivity and impairs the antiviral efficacy of microbicides.

Zirafi O, Kim KA, Roan NR, Kluge SF, Müller JA, Jiang S, Mayer B, Greene WC, Kirchhoff F, Münch J.

Sci Transl Med. 2014 Nov 12;6(262):262ra157. doi: 10.1126/scitranslmed.3009634.

18.

New candidate biomarkers in the female genital tract to evaluate microbicide toxicity.

Fields S, Song B, Rasoul B, Fong J, Works MG, Shew K, Yiu Y, Mirsalis J, D'Andrea A.

PLoS One. 2014 Oct 21;9(10):e110980. doi: 10.1371/journal.pone.0110980. eCollection 2014.

19.

Cultivated vaginal microbiomes alter HIV-1 infection and antiretroviral efficacy in colonized epithelial multilayer cultures.

Pyles RB, Vincent KL, Baum MM, Elsom B, Miller AL, Maxwell C, Eaves-Pyles TD, Li G, Popov VL, Nusbaum RJ, Ferguson MR.

PLoS One. 2014 Mar 27;9(3):e93419. doi: 10.1371/journal.pone.0093419. eCollection 2014.

20.

Seminal plasma induces global transcriptomic changes associated with cell migration, proliferation and viability in endometrial epithelial cells and stromal fibroblasts.

Chen JC, Johnson BA, Erikson DW, Piltonen TT, Barragan F, Chu S, Kohgadai N, Irwin JC, Greene WC, Giudice LC, Roan NR.

Hum Reprod. 2014 Jun;29(6):1255-70. doi: 10.1093/humrep/deu047. Epub 2014 Mar 13.

Supplemental Content

Support Center